-
Advancing ADC Linker and Antibody Conjugation Technology for the Development of Homogenous Antibody Drug Conjugates
Jun , 25 2024
Rising interest in ADC linker and antibody conjugation technology for the development of homogenous antibody drug conjugates (ADCs) is driven by the need for targeted cancer therapies with improved sa...
read more
-
Differentiating Strengths: The Clinical and Practical Merits of Avatrombopag maleate
Jan , 13 2026
Within the class of thrombopoietin receptor agonists (TPO-RAs), avatrombopag maleate demonstrates several distinct advantages that solidify its position in clinical practice. 1. Superior Profile Desig...
read more